Empirical data on the varicella situation in Germany for vaccination decisions
- 1 May 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (5) , 425-430
- https://doi.org/10.1111/j.1469-0691.2004.00853.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Seroprevalence of varicella-zoster virus in the German populationVaccine, 2001
- ID3: PRELIMINARY EVALUATION OF THE CLINICAL AND ECONOMIC BENEFITS OF UNIVERSAL VARICELLA VACCINATION OF CHILDREN IN GERMANYValue in Health, 2000
- Varicella Mortality: Trends before Vaccine Licensure in the United States, 1970–1994The Journal of Infectious Diseases, 2000
- Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practiceThe Pediatric Infectious Disease Journal, 1999
- A cost benefit analysis of routine varicella vaccination in SpainVaccine, 1999
- The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in FranceVaccine, 1998
- Direct and indirect costs of chickenpox in young childrenJournal of Paediatrics and Child Health, 1998
- Efficacy Of High-Titer Live Attenuated Varicella Vaccine In Healthy Young ChildrenThe Journal of Infectious Diseases, 1996
- Costs And Benefits Of Routine Varicella Vaccination In German ChildrenThe Journal of Infectious Diseases, 1996
- Epidemiologic effects of vaccines with complex direct effects in an age-structured populationMathematical Biosciences, 1994